Matthew Roden owns 0.17% of Aktis Oncology
91,998 shares as of the January 8, 2026 filing, worth $1.4M at the latest close.
AKTS · $838M market capGet an email when Matthew Roden’s stake moves.
Free.
The stake
0.17%
worth $1.4M at the latest close
Stake rank
#2,552
by dollar value of the stake
Last sale
None
no sales since 2016
Last buy
None
no purchases since 2016
Matthew Roden owns 0.17% of Aktis Oncology, Inc.: 91,998 of 55,619,499 shares, worth about $1.4M at the 2026-10-16 close. The stake has moved from 0.17% in 2026 to 0.17% on 2026-06-30.
How the stake is held
as of the Jan 8, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Jan 8, 2026 · Form 4 ↗
HELD DIRECTLY
91,998
100.0%
THE STAKE
91,998
0.17%